Answers are grounded in this paper and cite their sources.
Background: Pulmonary hypertension (PH) is a progressive cardiopulmonary disorder that affects the lung vasculature, leading to right heart failure and unacceptable high morbidity and mortality. Our previous data shows microglial activation, glial cytokine production, and maladaptive neuronal remodeling in key autonomic regions such as the hypothalamic paraventricular nucleus (PVN) as potential contributors to a sustained increase in sympathetic drive, establishing a feed-forward loop between injured lung vasculature and diseased brain networks. Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) has emerged as a key regulator of tissue remodeling. Our previous results show increased TREM2 expression in myeloid cells in the lung and PVN in PH models, and global TREM2 deletion in mice provides strong protection against hypoxia-induced PH, reducing pulmonary vascular remodeling and inflammatory activation in both the lung and PVN. Single-cell RNA-seq analysis of human pulmonary arteries confirmed TREM2 upregulation in PH patients. These findings indicate TREM2 as a potential regulator linking peripheral inflammation, neuroinflammation, and sympathetic dysregulation in PH. Aim: To evaluate the specific contribution of TREM2 expression in peripheral myeloid cells versus brain-resident microglia to the development of PH. Methods: For microglia-specific depletion of TREM2, CX3CR1-CreER;Trem2^fl/fl mice were treated with tamoxifen (75 mg/Kg/day) for 6 consecutive days, 8 weeks before the experiment, to activate Cre-lox recombination. LysM-Cre;TREM2fl/fl mice were used for conditional peripheral TREM2 knockout. Transgenic (Cre-/Cre+) and wild-type (WT) mice were exposed to chronic hypoxia (10% O 2 ) for 28 days to induce PH (CH-PH) or normoxia (Nx) (n=5-8 per group). Right ventricular systolic pressure (RVSP) was measured via right heart catheterization. Brain sections were stained for Iba1 to assess microglial activation in the PVN (n=3). Results: After hypoxia, CX3CR1-CreER+;Trem2^fl/fl mice showed significantly lower RVSP than WT and their CreER- counter-mates (RVSP: 29±2.1 vs. 37±2 mmHg vs 35±1.19 mmHg, p< 0.01), indicating that depletion of TREM on microglia leads to protection against CH-PH. LysM-Cre;TREM2fl/fl mice showed similar RVSP to WT mice (35±1.7 vs. 37±2 mmHg in WT, P=0.12). After hypoxia, Iba1 density in the PVN increased significantly in WT mice, as well as in the LysM-Cre;TREM2fl/fl Cre− and Cre+ mice (P< 0.0045 for Cre-; P< 0.0001 for Cre+ Nx vs Hx, n=3). Conversely, TREM2 deficiency on microglia attenuated the increase in PVN Iba1 immunoreactivity induced by hypoxia, showing significantly lower microglial activation than the CreER- littermates exposed to hypoxia (P< 0.0019 for CreER+ vs CreER-, n=3) and LysM-Cre;TREM2fl/fl mice (P< 0.0001 for CX3CR1-CreER+;Trem2^fl/fl vs LysM-Cre;TREM2fl/fl Cre- and Cre+, n=3). These results indicate that TREM2 expression in brain resident microglia contributes to the development of pulmonary hypertension induced by chronic hypoxia. Conclusion: Remarkably, deleting TREM2 specifically in microglia, but not in peripheral myeloid cells, was sufficient to protect against hypoxia-induced pulmonary hypertension. This highlights the brain’s contribution to the pathophysiology of PH and an unexplored therapeutic target in pulmonary hypertension. The authors acknowledge the National Institutes of Health for funding support (R00 HL165026). This abstract was presented at the American Physiology Summit 2026 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: